MAPK14 and chronic obstructive pulmonary disease: By unraveling the intricate mechanisms at play, we can develop more targeted and effective therapies that selectively modulate p38 activity, striking a balance between suppressing inflammation and preserving beneficial cellular functions for optimal COPD management.